| 2922 |
10.1007/s40121-018-0214-1 |
Effect And Safety Of Meropenem<U+2013>Vaborbactam
Versus Best-Available Therapy In Patients With Carbapenem-Resistant
Enterobacteriaceae Infections: The Tango Ii Randomized Clinical
Trial |
Wunderink, Richard G.; Giamarellos-Bourboulis,
Evangelos J.; Rahav, Galia; Mathers, Amy J.; Bassetti, Matteo; Vazquez,
Jose; Cornely, Oliver A.; Solomkin, Joseph; Bhowmick, Tanaya; Bishara,
Jihad; Daikos, George L.; Felton, Tim; Furst, Maria Jose Lopez; Kwak,
Eun Jeong; Menichetti, Francesco; Oren, Ilana; Alexander, Elizabeth L.;
Griffith, David; Lomovskaya, Olga; Loutit, Jeffery; Zhang, Shu; Dudley,
Michael N.; Kaye, Keith S. |
Infectious Diseases And Therapy |
2018 |
| 2932 |
10.1007/s40265-019-1055-2 |
Cefiderocol: A Siderophore Cephalosporin With Activity
Against Carbapenem-Resistant And Multidrug-Resistant Gram-Negative
Bacilli |
Zhanel, George G.; Golden, Alyssa R.; Zelenitsky,
Sheryl; Wiebe, Karyn; Lawrence, Courtney K.; Adam, Heather J.; Idowu,
Temilolu; Domalaon, Ronald; Schweizer, Frank; Zhanel, Michael A.;
Lagace-Wiens, Philippe R. S.; Walkty, Andrew J.; Noreddin, Ayman; Lynch
Iii, Joseph P.; Karlowsky, James A. |
Drugs |
2019 |
| 6287 |
10.1016/j.ijantimicag.2018.10.007 |
|
Kazmierczak, Krystyna M.; Tsuji, Masakatsu; Wise, Mark
G.; Hackel, Meredith; Yamano, Yoshinori; Echols, Roger; Sahm, Daniel
F. |
International Journal Of Antimicrobial Agents |
2019 |
| 6288 |
10.1016/j.ijantimicag.2018.11.001 |
Ceftolozane/Tazobactam For The Treatment Of Serious
Pseudomonas Aeruginosa Infections: A Multicentre Nationwide Clinical
Experience |
Bassetti, Matteo; Castaldo, Nadia; Cattelan, Annamaria;
Mussini, Cristina; Righi, Elda; Tascini, Carlo; Menichetti, Francesco;
Mastroianni, Claudio Maria; Tumbarello, Mario; Grossi, Paolo; Artioli,
Stefania; Carannante, Novella; Cipriani, Ludovica; Coletto, Davide;
Russo, Alessandro; Digaetano, Margherita; Losito, Angela Raffaella;
Peghin, Maddalena; Capone, Alessandro; Nicole, Stefano; Vena, Antonio;
Bassetti, Matteo; Vena, Antonio; Castaldo, Nadia; Pecori, Davide; Righi,
Elda; Carnellutti, Alessia; Givone, Filippo; Graziano, Elena; Merelli,
Maria; Cadeo, Barbara; Peghin, Maddalena; Cattelan, Annamaria; Cipriani,
Ludovica; Coletto, Davide; Mussini, Cristina; Digaetano, Margherita;
Tascini, Carlo; Carannante, Novella; Menichetti, Francesco; Verdenelli,
Stefano; Fabiani, Silvia; Mastroianni, Claudio Maria; Gianluca, Russo;
Oliva, Alessandra; Ciardi, Maria Rosa; Ajassa, Camilla; Tieghi, Tiziana;
Tumbarello, Mario; Losito, Angela Raffaella; Raffaelli, Francesca;
Grossi, Paolo; Rovelli, Cristina; Artioli, Stefania; Caruana, Giorgia;
Luzzati, Roberto; Bontempo, Giulia; Petrosillo, Nicola; Capone,
Alessandro; Rizzardini, Giuliano; Coen, Massimo; Passerini, Matteo;
Mastroianni, Antonio; Urso, Filippo; Bianco, Maria Francesca; Borgia,
Guglielmo; Gentile, Ivan; Maraolo, Alberto Enrico; Crapis, Massimo;
Venturini, Sergio; Parruti, Giustino; Trave, Francesca; Angarano,
Gioacchino; Carbonara, Sergio; Mariani, Michele Fabiano; Girardis,
Massimo; Cascio, Antonio; Gioe, Claudia; Anselmo, Marco; Malfatto,
Emanuele |
International Journal Of Antimicrobial Agents |
2019 |
| 6289 |
10.1016/j.ijantimicag.2018.11.007 |
In Vitro Activity Of Cefiderocol, A Siderophore
Cephalosporin, Against Gram-Negative Bacilli Isolated By Clinical
Laboratories In North America And Europe In 2015-2016:
Sidero-Wt-2015 |
Karlowsky, James A.; Hackel, Meredith A.; Tsuji,
Masakatsu; Yamano, Yoshinori; Echols, Roger; Sahm, Daniel F. |
International Journal Of Antimicrobial Agents |
2019 |
| 10357 |
10.1016/s1473-3099(18)30554-1 |
Cefiderocol Versus Imipenem-Cilastatin For The
Treatment Of Complicated Urinary Tract Infections Caused By
Gram-Negative Uropathogens: A Phase 2, Randomised, Double-Blind,
Non-Inferiority Trial |
Portsmouth, Simon; Van Veenhuyzen, David; Echols,
Roger; Machida, Mitsuaki; Ferreira, Juan Camilo Arjona; Ariyasu, Mari;
Tenke, Peter; Nagata, Tsutae Den |
The Lancet Infectious Diseases |
2018 |
| 10360 |
10.1016/s1473-3099(19)30403-7 |
Ceftolozane<U+2013>Tazobactam Versus Meropenem
For Treatment Of Nosocomial Pneumonia (Aspect-Np): A Randomised,
Controlled, Double-Blind, Phase 3, Non-Inferiority Trial |
Kollef, Marin H; Nova<U+010D>ek, Martin;
Kivistik, Ulo; Rea-Neto, Alvaro; Shime, Nobuaki; Martin-Loeches,
Ignacio; Timsit, Jean-Francois; Wunderink, Richard G; Bruno, Christopher
J; Huntington, Jennifer A; Lin, Gina; Yu, Brian; Butterton, Joan R;
Rhee, Elizabeth G |
The Lancet Infectious Diseases |
2019 |
| 10376 |
10.1016/s1473-3099(20)30731-3 |
Cefiderocol Versus High-Dose, Extended-Infusion
Meropenem For The Treatment Of Gram-Negative Nosocomial Pneumonia
(Apeks-Np): A Randomised, Double-Blind, Phase 3, Non-Inferiority
Trial |
Wunderink, Richard G; Matsunaga, Yuko; Ariyasu, Mari;
Clevenbergh, Philippe; Echols, Roger; Kaye, Keith S; Kollef, Marin;
Menon, Anju; Pogue, Jason M; Shorr, Andrew F; Timsit, Jean-Francois;
Zeitlinger, Markus; Nagata, Tsutae D |
The Lancet Infectious Diseases |
2021 |
| 10377 |
10.1016/s1473-3099(20)30796-9 |
Efficacy And Safety Of Cefiderocol Or Best Available
Therapy For The Treatment Of Serious Infections Caused By
Carbapenem-Resistant Gram-Negative Bacteria (Credible-Cr): A Randomised,
Open-Label, Multicentre, Pathogen-Focused, Descriptive, Phase 3
Trial |
Bassetti, Matteo; Echols, Roger; Matsunaga, Yuko;
Ariyasu, Mari; Doi, Yohei; Ferrer, Ricard; Lodise, Thomas P; Naas,
Thierry; Niki, Yoshihito; Paterson, David L; Portsmouth, Simon;
Torre-Cisneros, Julian; Toyoizumi, Kiichiro; Wunderink, Richard G;
Nagata, Tsutae D |
The Lancet Infectious Diseases |
2021 |
| 15979 |
10.1056/nejmc1807634 |
Plazomicin For Infections Caused By
Carbapenem-Resistant Enterobacteriaceae |
Mckinnell, James A.; Dwyer, Jamie P.; Talbot, George
H.; Connolly, Lynn E.; Friedland, Ian; Smith, Alex; Jubb, Adrian M.;
Serio, Alisa W.; Krause, Kevin M.; Daikos, George L. |
New England Journal Of Medicine |
2019 |
| 16052 |
10.1056/nejmoa1801467 |
Once-Daily Plazomicin For Complicated Urinary Tract
Infections |
Wagenlehner, Florian M.E.; Cloutier, Daniel J.;
Komirenko, Allison S.; Cebrik, Deborah S.; Krause, Kevin M.; Keepers,
Tiffany R.; Connolly, Lynn E.; Miller, Loren G.; Friedland, Ian; Dwyer,
Jamie P. |
New England Journal Of Medicine |
2019 |
| 17094 |
10.1093/cid/ciy1029 |
Ignite4: Results Of A Phase 3, Randomized, Multicenter,
Prospective Trial Of Eravacycline Vs Meropenem In The Treatment Of
Complicated Intraabdominal Infections |
Solomkin, Joseph S; Gardovskis, Janis; Lawrence,
Kenneth; Montravers, Philippe; Sway, Angie; Evans, David; Tsai,
Larry |
Clinical Infectious Diseases |
2018 |
| 17097 |
10.1093/cid/ciz530 |
Restore-Imi 1: A Multicenter, Randomized, Double-Blind
Trial Comparing Efficacy And Safety Of Imipenem/Relebactam Vs Colistin
Plus Imipenem In Patients With Imipenem-Nonsusceptible Bacterial
Infections |
Motsch, Johann; Murta De Oliveira, Claudia; Stus,
Viktor; Koksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W; Kaye, Keith
S; File, Thomas M; Brown, Michelle L; Khan, Ireen; Du, Jiejun; Joeng,
Hee-Koung; Tipping, Robert W; Aggrey, Angela; Young, Katherine;
Kartsonis, Nicholas A; Butterton, Joan R; Paschke, Amanda |
Clinical Infectious Diseases |
2019 |
| 17098 |
10.1093/cid/ciz825 |
The Role Of Iron And Siderophores In Infection, And The
Development Of Siderophore Antibiotics |
Page, Malcom G P, 0000-0002-0276-8174 |
Clinical Infectious Diseases |
2019 |
| 17099 |
10.1093/cid/ciz826 |
Cefiderocol: Discovery, Chemistry, And In Vivo Profiles
Of A Novel Siderophore Cephalosporin |
Sato, Takafumi; Yamawaki, Kenji |
Clinical Infectious Diseases |
2019 |